COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 664: Articles 6631-6640  | Next

Monkeypox caused less worry than COVID-19 among the general population during the first month of the WHO Monkeypox alert
Temsah, M.-H., Aljamaan, F., Alenezi, S., Alhasan, K., Saddik, B., Al-Barrag, A., Alhaboob, A., Bahabri, N., Alshahrani, F., Alrabiaah, A., Alaraj, A., Bahkali, F., Alkriadees, K., Jamal, A., Halwani, R., AlZamil, F., Alsubaie, S., Barry, M., Memish, Z. A., Al-Tawfiq, J. A.
10.1101/2022.07.07.22277365 — Posted: 2022-07-10
Feasibility of and Experience with Telehealth Based Patient Self-referral for COVID-19 Monoclonal Antibody Therapy
Gupta, I., Purekal, S., Shaikh, Y., Michtalik, H. J., Wortman, L., Vaeth, M. E., Locke, C. F. S., Hoemeke, E., Hariharan, R., Callahan, C. D., Ficke, J. R., Pimenta, I., Auwaerter, P. G., Kantsiper, M. E., CONQUER COVID Consortium, , Siddiqui, Z. K.
10.1101/2022.07.07.22277363 — Posted: 2022-07-10
A Case-Crossover Phenome-wide Association Study (PheWAS) for Understanding Post-COVID-19 Diagnosis Patterns
Haupert, S. R., Shi, X., Chen, C., Fritsche, L. G., Mukherjee, B.
10.1101/2022.07.07.22277394 — Posted: 2022-07-09
Brain imaging and neuropsychological assessment of individuals recovered from mild to moderate SARS-CoV-2 infection
Petersen, M., Naegele, F. L., Mayer, C., Schell, M., Petersen, E., Kuehn, S., Gallinat, J., Fiehler, J., Pasternak, O., Matschke, J., Glatzel, M., Twerenbold, R., Gerloff, C., Thomalla, G., Cheng, B.
10.1101/2022.07.08.22277420 — Posted: 2022-07-09
The role of SARS-CoV-2 genomic surveillance and innovative analytical platforms for informing public health preparedness in Bengaluru, India.
Harsha, P. K., Pattabiraman, C., George, A. K., J., M., Mardikar, S., Nazaar, M., Adimoolam, S., A., D. P., Pitale, J., Nagarajan, M., Sridharan, S., Kannan, Y., Janakiraman, A., Veeramachaneni, V., Hariharan, R., Rao, V. U., Shariff, M., Chandra, T., Sudhakar, K., Dev, R., Vasanthapuram, R., Chandru, V.
10.1101/2022.07.07.22276915 — Posted: 2022-07-09
Analysing COVID treatment outcomes in dedicated wards at a large university hospital in northern Poland. A result-based observational study.
Palus, D. K., Gołebiewska, M. E., Piatek, O., Majeranowski, A., Owczuk, R., Kuziemski, K., Stefaniak, T.
10.1101/2022.07.07.22277395 — Posted: 2022-07-09
Healthcare utilization following SARS-CoV-2 infection in children and adolescents with chronic conditions: An EHR-based Cohort Study from the RECOVER Program
Pajor, N. M., Lorman, V., Razzaghi, H., Case, A., Prahalad, P., Bose-Brill, S., Wu, Q., Chen, Y., Block, J. P., Patel, P. B., Rao, S., Mejias, A., Thacker, D., Jhaveri, R., Bailey, L. C., Forrest, C. B., Lee, G. M.
10.1101/2022.07.08.22276768 — Posted: 2022-07-09
Manifestations Associated with Post Acute Sequelae of SARS-CoV2 Infection (PASC) Predict Diagnosis of New-Onset Psychiatric Disease: Findings from the NIH N3C and RECOVER Studies
Coleman, B., Casiraghi, E., Callahan, T. J., Blau, H., Chan, L., Laraway, B., Clark, K. B., Re'em, Y., Gersing, K. R., Wilkins, K., Harris, N., Valentini, G., Haendel, M. A., Reese, J., Robinson, P. N., N3C Consortium, , RECOVER Consortium
10.1101/2022.07.08.22277388 — Posted: 2022-07-09
Medical complaints after 3 vs 2 doses SARS-CoV-2 mRNA vaccination
Methi, F., Gran, J. M., Valberg, M., Kinge, J. M., Telle, K. E., Magnusson, K.
10.1101/2022.07.08.22277413 — Posted: 2022-07-09
Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the Omicron period: cross sectional study
Venekamp, R. P., Schuit, E., Hooft, L., Veldhuijzen, I. K., Bijllaardt, W., Pas, S. D., Zwart, V. F., Lodder, E. B., Hellwich, M., Koppelman, M., Molenkamp, R., Wijers, C., Vroom, I. H., Smeets, L. C., Nagel-Imming, C. R., Han, W. G., van den Hof, S., Kluytmans, J. A., van de Wijgert, J. H., Moons, K. G.
10.1101/2022.07.07.22277366 — Posted: 2022-07-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).